Depression, Anxiety, Quality of Life, Race-related Stress, Stress Reaction
Conditions
Keywords
Black, African American, Adolescents, Acceptance and Commitment Therapy, race-related stress, racial trauma, coping
Brief summary
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
Interventions
BEHAVIORALACT for SCD
Phase I Using a convenience sample, this study examines the feasibility and acceptability of a proposed 6-session ACT group intervention for Black youth with sickle cell disease (SCD), who experience compounded stress due to chronic illness and systemic inequities. A up to 11 youth and up to 11 parents/legal guardians will be enrolled in an ACT group offered via the Division of Adolescent and Young Adult Medicine. Participants will complete assessments at pre-, and post-intervention, and at a 3-month follow-up. Up to 5 of 11 parents/legal guardians and 5 of 11 youth (not required to be dyadic) will also be a part of the studies community advisory board (CAB) to ensure the intervention is culturally and developmentally responsive and grounded in community perspectives. Phase II Over the next 3 years this study will use a community-based participatory action research approach, extending and integrating feedback data collected in Phase I, to conduct a crossover waitlist-control trial.
Sponsors
Children's Hospital Los Angeles
University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
Study design
Allocation
NA
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
14 Years to 21 Years
Healthy volunteers
No
Inclusion criteria
Youth Participant Inclusion and
Exclusion criteria
The inclusion criteria for study participation are Be an adolescent and/or young adult (age 14-21) who has Sickle Cell Disease Willing to enroll in the ACT group jointly provided by the Division of Adolescent and Young Adult Medicine/Department of Hematology and Oncology Participants can be active, waitlisted, or new patients at CHLA Participants must be able to understand and speak English, as the therapy will only be delivered in English Participants must have an English-speaking parent/guardian Able to provide consent/assent An adolescent or young adult that is pregnant is eligible to participate if consent can be obtained Participants must be developmentally typical Have a stable internet connection (via computer, tablet, or phone) with access to a webcam and a private space to engage in a group therapy sessions; Must consent to audio and video recording of initial interview. Must agree to attend 6 weekly ACT group session Youth participants will be asked to become a member of the CAB. To become a CAB member, the youth participant must consent/assent to participation in the ACT intervention. If a CAB member, they must be willing to engage in CAB interviews and meetings. The
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total Score on Index of Race-Related Stress (IRRS)-Brief Version | 12 weeks | Higher scores on this measure indicate greater race-related stress. The minimum score on this measure is 0 and the maximum is 88. |
| Sickle Cell Self-Efficacy Scale | 6 mos | a 9-item, self-administered questionnaire that measures an adult's confidence in managing sickle cell disease (SCD) day-to-day, including pain, emotions, and daily functioning. |
| SCD Health-Related Internalized Stigma Scale | 6 mos | an 11-item tool assessing internalized stigma and other factors in sickle cell disease (SCD) patients |
| Transition Readiness Assessment Questionnaire (TRAQ), | 6 mos | measure acquisition of transition readiness skills across the five stages of change |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total Scores on Acceptance and Action Questionnaire-2 | 12 weeks | Higher scores on this measure indicate greater psychological flexibility. The minimum score on this measure is 7 and the maximum is 49. |
| Total Scores on Multidimensional Inventory of Black Identity-Teen (MIBI-t) | 12 weeks | Higher scores on this measure indicate stronger racial identity. The minimum score on this measure is 21 and the maximum is 105. |
| Total Score on Patient Health Questionaire-9 | 12 weeks | Higher scores indicate greater depression. The minimum score on this measure is 0 and the maximum is 27. |
| Total Score on General Anxiety Disorder-7 | 12 weeks | Higher scores indicate greater anxiety. The minimum score on this measure is 0 and the maximum is 21. |
Countries
United States
Contacts
CONTACTXzania Lee, PhD
PRINCIPAL_INVESTIGATORXzania Lee, PhD
Children's Hospital Los Angeles
Outcome results
None listed